SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : UNITED STATES OF AMERICA -- Ignore unavailable to you. Want to Upgrade?

To: goldworldnet who wrote (60)3/11/2006 10:51:56 AM
From: DuckTapeSunroof  Read Replies (1) | Respond to of 143
 
Not exactly true.

They can't make a vaccine that will be effective against a specific strain (generally) until that strain actually evolves into being, and so is available for testing.

Any traditional vaccine made to target the current H5N1 strain that's going around (which is NOT very contractible by humans yet) might or might not have any significant degree of effectiveness against a future 'killer pandemic strain'.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News